These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18354205)

  • 21. Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89.
    van Zandbergen G; Westerhuis R; Mohamad NK; van De Winkel JG; Daha MR; van Kooten C
    J Immunol; 1999 Dec; 163(11):5806-12. PubMed ID: 10570263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the ligand binding site of the bovine IgA Fc receptor (bFc alpha R).
    Morton HC; Pleass RJ; Woof JM; Brandtzaeg P
    J Biol Chem; 2004 Dec; 279(52):54018-22. PubMed ID: 15485844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human IgA-Fc alpha receptor interaction and its blockade by streptococcal IgA-binding proteins.
    Woof JM
    Biochem Soc Trans; 2002 Aug; 30(4):491-4. PubMed ID: 12196121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
    Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
    PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils.
    Pleass RJ; Andrews PD; Kerr MA; Woof JM
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):771-7. PubMed ID: 8836118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
    J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Streptococcal IgA-binding proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding of IgA to human CD89.
    Pleass RJ; Areschoug T; Lindahl G; Woof JM
    J Biol Chem; 2001 Mar; 276(11):8197-204. PubMed ID: 11096107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells.
    Toyabe S; Kuwano Y; Takeda K; Uchiyama M; Abo T
    Clin Exp Immunol; 1997 Nov; 110(2):226-32. PubMed ID: 9367406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA; van Egmond M
    Immunol Lett; 2004 Mar; 92(1-2):23-31. PubMed ID: 15081523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C/EBP alpha and Ets protein family members regulate the human myeloid IgA Fc receptor (Fc alpha R, CD89) promoter.
    Shimokawa T; Ra C
    J Immunol; 2003 Mar; 170(5):2564-72. PubMed ID: 12594283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhesus macaque antibody molecules: sequences and heterogeneity of alpha and gamma constant regions.
    Scinicariello F; Engleman CN; Jayashankar L; McClure HM; Attanasio R
    Immunology; 2004 Jan; 111(1):66-74. PubMed ID: 14678200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monomeric and polymeric IgA show a similar association with the myeloid FcalphaRI/CD89.
    Oortwijn BD; Roos A; van der Boog PJ; Klar-Mohamad N; van Remoortere A; Deelder AM; Daha MR; van Kooten C
    Mol Immunol; 2007 Feb; 44(5):966-73. PubMed ID: 16675016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FcαRI binding at the IgA1 C
    Posgai MT; Tonddast-Navaei S; Jayasinghe M; Ibrahim GM; Stan G; Herr AB
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8882-E8891. PubMed ID: 30181292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.
    Deo YM; Sundarapandiyan K; Keler T; Wallace PK; Graziano RF
    J Immunol; 1998 Feb; 160(4):1677-86. PubMed ID: 9469424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA-specific proteins of pathogenic bacteria.
    Kazeeva TN; Shevelev AB
    Biochemistry (Mosc); 2009 Jan; 74(1):12-21. PubMed ID: 19232043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules.
    Villinger F; Bostik P; Mayne A; King CL; Genain CP; Weiss WR; Ansari AA
    Immunogenetics; 2001; 53(4):315-28. PubMed ID: 11491535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Size-dependent effect of IgA on the IgA Fc receptor (CD89).
    Reterink TJ; van Zandbergen G; van Egmond M; Klar-Mohamad N; Morton CH; van de Winkel JG; Daha MR
    Eur J Immunol; 1997 Sep; 27(9):2219-24. PubMed ID: 9341762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
    van Egmond M; van Garderen E; van Spriel AB; Damen CA; van Amersfoort ES; van Zandbergen G; van Hattum J; Kuiper J; van de Winkel JG
    Nat Med; 2000 Jun; 6(6):680-5. PubMed ID: 10835685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB; Ballister ER; Bjorkman PJ
    Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.